Eurofins-Cerep Logo

Eurofins-Cerep

ALECR | PA

Overview

Corporate Details

ISIN(s):
FR0004042232 (+3 more)
LEI:
9695004C9D3ZX7FTZY16
Country:
France
Address:
2 RUE DU PROFESSEUR GARGOUIL, 86600 CELLE-LEVESCAULT
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Eurofins-Cerep is a contract research organization (CRO) specializing in preclinical drug discovery and development services for the pharmaceutical and biotechnology industries. Founded in December 1989, the company provides a range of solutions including in vitro drug profiling, drug screening, and pharmacology testing. As a part of the broader Eurofins Discovery division, it supports clients in the early stages of developing new pharmaceutical drugs, leveraging its long-standing expertise in the field.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Eurofins-Cerep. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2019-04-29 00:00
Annual Report
rapport annuel 2018
French 5.2 MB
2018-05-02 08:57
Annual Report
Rapport financier annuel 2017
French 1.4 MB
2017-04-28 19:00
Annual / Quarterly Financial Statement
RAPPORT FINANCIER ANNUEL
French 1.6 MB
2017-01-27 18:20
Share Issue/Capital Change
Eurofins-Cerep annonce la fin de la période de regroupement d'actions
French 367.5 KB
2016-10-26 19:03
Interim Report
Rapport Financier Semestriel - 1er semestre 2016
French 506.8 KB
2016-04-29 21:30
Annual Report
RAPPORT FINANCIER ANNUEL
French 11.0 MB
2015-10-29 11:43
Interim Report
RAPPORT FINANCIER SEMESTRIEL - SEMESTRE CLOS LE 30 JUIN 2015
French 557.7 KB
2015-10-28 19:00
Earnings Release
Eurofins-Cerep annonce ses résultats du 1er semestre 2015
French 237.1 KB
2015-05-27 13:29
Management Discussion and Analysis
RAPPORT ANNUEL 2014
French 1.5 MB
2015-01-14 15:00
Share Issue/Capital Change
Avis préalable à la mise en vente d'actions non réclamées
French 193.4 KB
2015-01-14 14:21
Post-Annual General Meeting Information
Avis de regroupement d'actions (BALO du 17 décembre 2014 - Bulletin n° 151)
French 120.4 KB
2014-04-30 16:15
Management Discussion and Analysis
Rapport Annuel 2013
French 2.2 MB
2010-03-29 15:00
Earnings Release
2009 consolidated results / Positive EBITDA in the second half
English 169.7 KB
2010-03-26 19:00
Earnings Release
Résultats consolidés 2009 : un EBE positif au second semestre
French 181.8 KB
2010-03-19 08:00
Delisting Announcement
Introduction aujourd’hui de Cerep sur Alternext
French 110.1 KB

Automate Your Workflow. Get a real-time feed of all Eurofins-Cerep filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Eurofins-Cerep via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN